ClinicalTrials.gov
public full text
Public Domain
China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population
To evaluate the safety and effectiveness of the SAPIEN XT (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic severe calcific aortic stenosis who are considered at high risk for surgical valve replacement.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Primary Non-invasive Cardiac Computed Tomography Versus Routine Invasive Angiography Prior to TAVI#993569
- E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms#874929
- Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China#968121
- Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device Implantation#858854
- ArterX Safety and Efficacy Study for Cardiac Indications#1245905
Record · ID 1260045
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive